Latest Options News

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

Venus Metals Corporation progresses its Sandstone Bellchambers gold project with a new mining lease and exploration targets, while extending its Bridgetown JV farm-in and navigating an unsolicited takeover offer.

Dalaroo Metals is fast-tracking its 2026 exploration program at the Blue Lagoon project in Greenland following promising 2025 results that confirmed widespread rare earth and critical mineralisation. The company aims to define drill-ready targets and advance its position in the strategic critical minerals sector.

Coventry Group reports a solid half-year sales and earnings improvement while initiating a strategic review following unsolicited takeover interest.

SSH Group Ltd reports a robust half-year performance with revenue up 25%, operational advances in gold projects, and a new strategic partnership enhancing its mining capabilities.

Lindian Resources has accelerated development at its Kangankunde Rare Earths Project, securing full ownership and awarding key construction contracts, while attracting strategic international attention.

Neometals has reported promising gold assay results from its Barrambie drilling program and secured substantial conditional funding for its Vanadium Recovery Project in Finland, while progressing new critical minerals opportunities in the US.

West Coast Silver has completed a significant phase of drilling at its Elizabeth Hill Silver Project, revealing visible native silver in multiple holes and securing $3.2 million in fresh capital to advance exploration and processing studies.

Rox Resources has confirmed the economic viability of its Youanmi Gold Project with a robust feasibility study and commenced underground mining, backed by a $218 million equity raise. The company is on track for first gold production by mid-2027.

Great Northern Minerals has reported promising initial antimony assay results from its newly acquired Catalyst Ridge Project and secured a patent option for advanced rare earth flotation technology from the University of Arizona.